Covered recipient · General Payments record
HART B MOSS
Allopathic & Osteopathic Physicians Ophthalmology Cornea and External Diseases Specialist
General Payments · PY2018–2024
$2,119.24
- Reported across 68 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $323.03 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GLAUKOS CORPORATION | $96.97 | 3 |
| NEW WORLD MEDICAL,INC. | $49.95 | 4 |
| RxSight Inc | $40.18 | 2 |
| ABBVIE INC. | $32.92 | 1 |
| Alcon Laboratories Inc | $23.97 | 1 |
| Harrow Eye, LLC | $23.00 | 1 |
| Tarsus Pharmaceuticals, Inc. | $22.40 | 1 |
| Oyster Point Pharma, Inc. | $20.55 | 1 |
| Ocular Therapeutix, Inc. | $13.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $32.92 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105072213 | CMS |
| Alcon Vision LLC | $23.97 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110563667 | CMS |
| Glaukos Corporation | $23.61 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151983688 | CMS |
| Glaukos Corporation | $37.45 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151977228 | CMS |
| Glaukos Corporation | $35.91 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151980322 | CMS |
| Harrow Eye, LLC | $23.00 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145610327 | CMS |
| NEW WORLD MEDICAL,INC. | $18.74 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137396236 | CMS |
| NEW WORLD MEDICAL,INC. | $12.86 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137398827 | CMS |
| NEW WORLD MEDICAL,INC. | $10.74 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137399307 | CMS |
| NEW WORLD MEDICAL,INC. | $7.61 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137400301 | CMS |
| Ocular Therapeutix, Inc. | $13.09 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148198941 | CMS |
| Oyster Point Pharma, Inc. | $20.55 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147411673 | CMS |
| RxSight Inc | $19.58 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144222499 | CMS |
| RxSight Inc | $20.60 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144222503 | CMS |
| Tarsus Pharmaceuticals, Inc. | $22.40 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139118808 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.